Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC H3B-6545 | 2052130-80-8 | 99.4% | 567.58 | 10 MG
Supplier: Medchemexpress LLC HY11259610MG
H3B-6545 is an oral, selective estrogen receptor covalent antagonist (SERCA) for the research of metastatic ER-positive, HER2-negative breast cancer. It is a first-in-class selective ER covalent antagonist (SERCA) that inactivates both wild-type and mutant ERα by targeting C530 and enforcing a unique antagonist conformation.
- Inactivates wild-type and mutant ERα by targeting C530.
- Enforces a unique antagonist conformation.
- Used for research of metastatic ER-positive, HER2-negative breast cancer.
- Shows potent activity in MCF-7 xenograft model.
- Well tolerated in rats and monkeys across a broad dose range.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?